PETER ROST M.D.

EXPERIENCED PHARMACEUTICAL MARKETING EXECUTIVE Distinguished senior executive with 20+ years of drug and medical device experience, leading various business organizations to exceptional growth. Managed a number of businesses; Managing Director, Wyeth Nordic Region with 4 affiliate companies; Vice President, Marketing, Women’s Healthcare Division, Wyeth; and Vice President, Marketing, Endocrine Care, Pharmacia. Business size from $100 million to $2.0 billion, encompassing between 70 and 175 employees. Significantly exceeded the companies’ financial goals and outperformed versus the overall industry. Broad base of experience is complemented with a medical degree from the University of Gothenburg as well as corporate-sponsored financial training by Columbia University. Public speaker on healthcare related matters, including speaking in the U.S. Senate and to numerous state governments and business organizations; writing engagements for major newspapers, including the New York Times and the Los Angeles Times, and legal consulting related to the drug industry for numerous law firms. Recognized as a solid business professional and an individual of the highest level of integrity and business judgment; quoted and interviewed by all major U.S. television networks and news outlets (CBS, ABC, FOX, CNN, CNBC, 60 Minutes, Wall Street Journal, New York Times, Los Angeles Times, USA Today, Fortune, Boston Globe, Bloomberg News and many others).

PROFESSIONAL EXPERIENCE

EXPERT WITNESS/SPEAKER/AUTHOR & WRITER, INSYNC COMMUNICATION, 12/2005-Present • SPEECHES ON DRUG INDUSTRY (not complete list): U.S. Senate, National Venture Capital Association, Governor of Indiana press conference, Governor of Montana press conference, Maryland Senate, Vermont Senate, New York City Council, Southern Medical Association, ESOMAR, NC Pharmacy Association, The Prescription Access Litigation Project, Minnesota Senior Federation, Danske Bank, Swedish Parliament, Swedish Radio, Svenska Nyhetsbrev AB, Entreprenörsdagen, Stockholms Läns Landsting, Läkemedelskommittén i Jämtlands län, Gräv 08-Undersökande Journalister, Västsvenska Industri- och Handelskammaren, Sveriges Läkarsällskap, Svenska Neurologföreningen, Hjärntrusten Management AB. WRITING ON DRUG INDUSTRY: The New York Times, Brandweek, Los Angeles Times, NJ Star-Ledger, CounterPunch, NJ Voices, Huffington Post, Realtid, Läkemedelsvärlden HEALTHCARE & DRUG-INDUSTRY RELATED BOOKS: Killer Drug, BookLocker, 2007; The Whistleblower, Confessions of a Healthcare Hitman, Soft Skull Press, 2006; Emergency Surgery, Student Literature, 1985. LEGAL CONSULTING ON DRUG INDUSTRY: For list of cases in which Dr. Rost testified as an expert at trial or by deposition see below.

• • •

PHARMACIA CORPORATION/PFIZER, INC., 6/2001 to 11/2005 Vice President, Marketing, Endocrine Care, June 2001 – November 2005 • Genotropin (growth hormone and injection device) became the #1 performing Pfizer product in the US vs. budget in 2003 (comparing products with sales $100 million+). US sales exceeded budget by 30%+. • Tripled US Genotropin sales from $75 million 2000 to $212 million 2003. • $600 million Global Business Unit. • Launched new product for acromegaly - Somavert in the US. Launched Genotropin indication Small for Gestational Age. • Unit included US Marketing, International Marketing and Outcomes Research, 70 employees. • In-dept analysis of business resulted in refocus of resources and organizational changes.

1

P E T E R

R O S T

M . D .

WYETH PHARMACEUTICALS, 3/1992 to 5/2001 Vice President, Marketing, Women’s Healthcare Division, February – May 2001 • Reported to President, Wyeth Women’s Healthcare Division. • WHC was Wyeth’s largest franchise with sales of $2.0 billion. Managing Director, Wyeth Nordic Region, January 1999 – January 2001 • Doubled affiliate sales in two years, to $123 million 2000 with 2001 sales of $155 million. • Wyeth Sweden increased from #19 position in 1999 to #7 in 2001 resulting in "President’s Award" for most increased affiliate market ranking. • Sales/IBT (profit) increase: 1999 +32.8%/+35.2%, 2000 +39.4%/+41.3%, 2001 +33%/+48%. • Increased market share for Lanzo, a proton pump inhibitor, from 8% to 30% in 12 months. • 175 employees, incl. 4 Country Managers, Finance, Regulatory, Medical, Marketing, HR, IT. Director of Commercial Operations, Europe, October 1996 – December 1998 • Reported to President, Europe/Africa/Middle East. 1997 Net sales $1.8 billion, +14.9% increase. • Reorganized German affiliate (1997 Net sales $320 million), including divestiture of two divisions, restructuring of product portfolio and local management. Head count reduction from 1383 to 1003 employees. Director of Marketing, Internal Medicine Products, October 1995 – September 1996 • International marketing responsibility for the gastroenterology (Zoton), diabetology (Alredase), dermatology (Minocin), cardiovascular (Ziac/bisoprolol) and rheumatology (Lodine) franchise. International Product Manager, Gastro/CV Products, January 1995 – September 1995 • Launched Zoton (antiulcerant) in international markets. • Management of Bisoprolol (betablocker). LEDERLE LABORATORIES - AMERICAN CYANAMID, 3/1992 to 12/1994 Product Manager, CNS, 1993 - 1994 • Prepared U.S. launch of Redux (CNS acting anti-obesity drug). • In-line management of ProStep (nicotine patch) in the U.S. market. Director, Medical Education, 1993, Associate Director, Medical Education, 1992 • Reorganized the Medical Education department including personnel restructuring. • Responsible for all of Lederle’s medical education/medical marketing programs: CME activities, symposia, phase IV programs, speaker and VIP programs. • Launched Ziac, an ultra-low dose betablocker/diuretic. MAHER, KAUMP & CLARK ADVERTISING, INC., 12/1987 to 2/1992 Account Supervisor Contract to become 50% partner negotiated in 1991. Major clients: BAXTER HEALTHCARE CORPORATION, HYLAND DIVISION • Launched Recombinate (recombinant Factor VIII). Also responsible for • Gammagard (immune globuline intravenous) and Hemofil M (plasma based FVIII). BECTON DICKINSON IMMUNOCYTOMETRY SYSTEMS • Launched new line of breakthrough flow cytometry equipment. PACESETTER • Pacemakers PHARMACIA OPHTHALMICS • Healon and intraocular lenses GREY MEDICAL - DIVISION OF GREY ADVERTISING, 10/1985 to 11/1987 Account Supervisor Created and built Grey Medical from zero to nine clients. Major clients:

2

P E T E R

R O S T

M . D .

• • • • • • • •

ASTRA – Launched Plendil (felodipine) and Toprol XL (metoprolol extended release). CIBA GEIGY – Launched Estraderm (estrogen patch). GLAXO – Established the first physicians’ lifestyle magazine in Sweden. JANSSEN – Haldol (haloperidol) antipsychotic. HEA REHAB – Wheelchairs MÖLNLYCKE HOSPITAL PRODUCTS – wound care products KABI VITRUM – blood derivatives MEDIC HERB – naturopathic products

BUSINESS LITERATURE, INC., 1985 Wrote The Art of Driving a Car Free and founded Business Literature to sell the book. President • Sold 10,000 copies the first year in the Swedish market with an 8 million population. Equivalent to 300,000 copies in the U.S. market. THE WEST SWEDISH MODEL GROUP, 1985 Model group (commercials, print) with two bookers and sixty models. Chairman • Rescued the agency from the verge of Chapter 11 proceedings and returned agency to profitability within six months. THE EASTERN HOSPITAL, 1984 Anesthesiology and emergency medicine department. Staff Physician • Responsible for anesthesiology, intensive care and helicopter emergency rescues.

FOREIGN LANGUAGES Swedish, German, limited French.

EDUCATION • Doctor of Medicine, University of Gothenburg, Sweden, January 1984. “These studies are considered equivalent in level and purpose to the Doctor of Medicine, awarded by accredited colleges and universities in the United States.” –International Education Research Foundation, Inc., Credentials Evaluation Service, August 11, 1989. Manager’s Workshop, Lederle Laboratories, 1992. Leadership Development Program, The Hartford Graduate Center, 1993. Accounting and Financial Management Program, Columbia University Graduate School of Business, 1994.

• • •

AUTHOR OF • • • • Killer Drug, BookLocker, 2007 The Whistleblower, Confessions of a Healthcare Hitman, Soft Skull Press, 2006 Emergency Surgery, Student Literature, 1985 The Art of Driving a Car Free, Business Literature, 1985

3

P E T E R

R O S T

M . D .

EXPERT TESTIMONY The following is a list of cases in which Dr. Rost testified as an expert at trial or by deposition: • • • • • • • • • • • • • • Judith Yarrington v. Solvay Pharmaceuticals, Inc. et al., U.S. District Court, First Judicial District, County of Dakota, State of Minnesota, Court File No: 19-C9-04-7261. Patricia Gwen Kiser v. The Purdue Pharma Company, et al., U.S. District Court, Southern District of Mississippi, Jackson Division, Court File No: 3:07cv419-HTW-LRA. Gilberto Hernandez and Ruth Elizondo v. Schering Corporation, et al., Circuit Court of Cook County, Illinois County Department, Law Division, Court File No: 04 L 9028 Charles Foti, Attorney General ex rel., v Janssen Pharmaceutica, Inc. et al, 27h Judicial District Court, Parish of St. Landry, Louisiana, Court File No: 04-C-3967-D Ralph Neal Plyler v. General Electric Co et al, Circuit Court of Jefferson County, Alabama, Bessemer Division, CV 07 1316 In re: Avandia Marketing, Sales Practices and Products Liability Litigation, U.S. District Court for the Eastern District of Pennsylvania, Civil Action No. MDL No. 1871, 07-MD-01871-CMR State of Idaho v. Sandoz, Inc., In Re Pharmaceutical Industry Average Wholesale Price Litigation MDL No. 1456 State of Hawaii v. Merck, In Re: Pharmaceutical Industry Average Wholesale Price Litigation, Civil No. 06-10720-04 EEH Commonwealth of Kentucky v. Alpharma, Purepac, In Re: Pharmaceutical Industry Average Wholesale Price Litigation, Franklin Circuit Court, Civil Action No 04-CI-1487 Kathleen Kerrigan v. General Electric Co et al, In the Court of Common Pleas, Philadelphia County, Case No. 01069, Sheila Glover v. General Electric Co et al, In the Court of Common Pleas, Philadelphia County, Case No. 01064 Neal Haley et al., v. Merial Limited/Merial LLC and Merial Inc., United States District Court for the Northern District of Mississippi, Greenville Division, Civil Action No: 4:09-CV-094-P-S Amanda Howton, John Howton, v. Medtronic Inc., Stuart Ison, Peter Lotze, M.D., In the District Court of Harris County, Texas, 125 Judicial District, Case No. 2009-47431 Mary Plubell and Ted Ivey v. Merck & Co, Inc., Circuit Court of Jackson County, Missouri, Case No. 04CV235817 Kevin Kerch and Injured Workers Pharmacy v. Steel Creations, Commonwealth of Kentucky, Department of Workers Claims, Frankfurt Motion Docket, Claim No. 2007-80884

Additionally Dr. Rost has testified in 2005 before the U.S. Senate Health Committee in a hearing regarding the drug industry. He has also testified about the drug industry before the Maryland Senate, the Maryland House of Delegates, the Vermont Senate, and the New York City Council.

4